title: Successful treatment of refractory cutaneous warts using topical 3% cidofovir in a child after heart transplant.
authors.affiliation: Departments of Paediatric Cardiology, Our Lady's Children's Hospital, Crumlin, Dublin, Ireland.
authors.forename: Aoife
authors.initials: A
authors.lastname: Cleary
authors.affiliation: Departments of Dermatology, Our Lady's Children's Hospital, Crumlin, Dublin, Ireland.
authors.forename: Rosemarie
authors.initials: R
authors.lastname: Watson
authors.affiliation: Departments of Paediatric Cardiology, Our Lady's Children's Hospital, Crumlin, Dublin, Ireland.
authors.forename: Colin J
authors.initials: CJ
authors.lastname: McMahon
mesh_terms: D000287:Administration, Topical; D000998:Antiviral Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D002648:Child; D000077404:Cidofovir; D003596:Cytosine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D005260:Female; D006084:Graft Rejection / Q000517:prevention & control; D016027:Heart Transplantation; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D009894:Opportunistic Infections / Q000188:drug therapy / Q000209:etiology; D063065:Organophosphonates / Q000008:administration & dosage* / Q000627:therapeutic use; D011184:Postoperative Period; D016896:Treatment Outcome; D014860:Warts / Q000188:drug therapy* / Q000209:etiology
chemical_list: D000998:Antiviral Agents; D007166:Immunosuppressive Agents; D063065:Organophosphonates; D003596:Cytosine; D000077404:Cidofovir